Insights

Innovative Isotope Production RadTran LLC has developed a patent-protected technology for cost-effective extraction of Ra224 and Ac225 isotopes from natural Th232 stockpiles, offering a scalable and reliable supply of critical materials for TAT cancer treatments, which can appeal to pharmaceutical firms seeking dependable isotope sources.

Growth in Cancer Therapies With a focus on advancing radioimmunotherapy, RadTran's technologies address a significant bottleneck in the cancer treatment market—limited isotope supply—presenting opportunities for partnerships with biotech companies developing new targeted alpha therapies.

Strategic Industry Partnerships Recent collaborations with Energy Fuels Inc. to evaluate thorium and radium recovery demonstrate RadTran’s potential to expand its supply chain and production capabilities, opening avenues for joint ventures or supply agreements with energy and resource companies aiming to diversify into medical isotopes.

Emerging Market Demand As TAT becomes more prominent in oncology, pharmaceutical and biotech companies investing in new cancer treatments are likely to seek RadTran’s affordable, scalable isotope solutions to accelerate drug development and commercialization efforts.

Technological Edge RadTran’s utilization of advanced technology infrastructure, including AWS and modern web protocols, indicates operational resilience and scalability that can support increased production volumes and facilitate broader collaborations within the biotech and pharmaceutical sectors.

Similar companies to RadTran LLC

RadTran LLC Tech Stack

RadTran LLC uses 8 technology products and services including Amazon Web Services, Google Hosted Libraries, jQuery, and more. Explore RadTran LLC's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • Google Hosted Libraries
    Content Delivery Network
  • jQuery
    Javascript Libraries
  • Webflow
    Page Builders
  • HSTS
    Security
  • HTTP/3
    Web & Portal Technology
  • OpenResty
    Web Servers
  • Nginx
    Web Servers

RadTran LLC's Email Address Formats

RadTran LLC uses at least 1 format(s):
RadTran LLC Email FormatsExamplePercentage
First.Last@radtran.comJohn.Doe@radtran.com
50%
First.Last@radtran.comJohn.Doe@radtran.com
50%

Frequently Asked Questions

Where is RadTran LLC's headquarters located?

Minus sign iconPlus sign icon
RadTran LLC's main headquarters is located at 5428 S Idalia Way, Centennial, Colorado, US. The company has employees across 1 continents, including North America.

What is RadTran LLC's official website and social media links?

Minus sign iconPlus sign icon
RadTran LLC's official website is radtran.com and has social profiles on LinkedIn.

What is RadTran LLC's SIC code NAICS code?

Minus sign iconPlus sign icon
RadTran LLC's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does RadTran LLC have currently?

Minus sign iconPlus sign icon
As of December 2025, RadTran LLC has approximately 1 employees across 1 continents, including North America. Key team members include Business Strategy Consultant: N. V.. Explore RadTran LLC's employee directory with LeadIQ.

What industry does RadTran LLC belong to?

Minus sign iconPlus sign icon
RadTran LLC operates in the Biotechnology Research industry.

What technology does RadTran LLC use?

Minus sign iconPlus sign icon
RadTran LLC's tech stack includes Amazon Web ServicesGoogle Hosted LibrariesjQueryWebflowHSTSHTTP/3OpenRestyNginx.

What is RadTran LLC's email format?

Minus sign iconPlus sign icon
RadTran LLC's email format typically follows the pattern of First.Last@radtran.com. Find more RadTran LLC email formats with LeadIQ.

When was RadTran LLC founded?

Minus sign iconPlus sign icon
RadTran LLC was founded in 2012.

RadTran LLC

Biotechnology ResearchUnited States0-1 Employees

RadTran LLC specializes in nuclear technologies for the advancement of medicine and energy production. Since its inception, RadTran LLC has provided valuable services for a host of international companies in the development and commercialization of new technologies. Currently, RadTran is working to develop and commercialize its own new technology to meet a pressing need in the development of radioimmunotherapy treatments for cancer.

Our Technology:
RadTran has developed a new approach for the generation of Ra224 and Ac225. These isotopes have been identified as the most desirable for TAT applications for both direct use and as prerequisites for two other leading medically-attractive isotopes, Pb212 and Bi213. Our patent protected technology enables the efficient extraction of target isotopes from naturally occurring stockpiles of Thorium 232 (Th232), a natural waste byproduct of mining, at a dramatically lower cost. The stable supply of material produced using our technology will give the pharmaceutical companies the means and confidence for the development of new drugs. Furthermore, it will also provide a scalable supply once the drugs receive commercial approval.

Applications for Cancer Treatment:
Targeted Alpha Therapies (TAT) are on the cutting edge of cancer treatment. TAT shows great potential to treat a wide range of cancers with a greatly reduced impact on surrounding healthy tissues. The components required for TAT are targeting mechanisms to seek out cancerous cells and radioactive isotopes to destroy the cancerous cells in the body. Existing supply for the appropriate isotopes is very limited and methods for production are exorbitantly expensive and cannot be scaled to meet the demand as new drugs are developed and approved. This shortage of isotope material is a major roadblock in the research and development of new TAT drugs as pharmaceutical companies wait for a scalable and affordable production technology to become available.

Section iconCompany Overview

Headquarters
5428 S Idalia Way, Centennial, Colorado, US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2012
Employees
0-1

Section iconFunding & Financials

  • $1M$10M

    RadTran LLC's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    RadTran LLC's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.